1. Airaksinen, E. M., Kauko, K.: Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down’s syndrome. Ann. Clin. Res.5:392–394, 1973.
2. Andersson, H., Roos, B.-E.: 5-Hydroxyindoleacetic acid in cerebrospinal fluid of hydrocephalic children. Acta Paediatr. Scand.58:601–608, 1969.
3. Aprille, J. R.: Reye’s syndrome: Patient serum alters mitochondrial function and morphology in vitro. Science197:908–910, 1977.
4. Azarro, A. J., Wenger, G. R., Craig, C. R., Stitzel, R. E.: Reserpine induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice. J. Pharmacol. Exp. Ther.180:558–568, 1972.
5. Bareggi, S. R., Porta, M., Selenati, A., Assael, B. M., Calderini, G., Collice, M., Rossanda, M., Morselli, P. L.: Homovanillic acid and 5-hydroxyindole-acetic acid in the CSF of patients after a severe head injury. Eur. Neurol.13:528–544, 1975.